first approved chimeric antigen receptor T-cell therapy and the first approved gene therapies for treating hemophilia...
science and technology (S&T) consistent with ORNL's aspiration to be the world's premier R&D institution and ORNL's science...
science and technology (S&T) consistent with ORNL’s aspiration to be the world’s premier R&D institution and ORNL’s science...
experiences. We encourage you to apply to a role even if your experience doesn't fully match the...
. We are continually innovating - challenging the way we, and the industry, think about cybersecurity. Our engineers don't shy away... that take risks and challenge cybersecurity's status quo. It's simple: we can't accomplish our mission without diverse teams...
't shy away from building products to solve problems no one has pursued before. We define the industry, instead... problem solvers that take risks and challenge cybersecurity's status quo. It's simple: we can't accomplish our mission...
cybersecurity company and collaborating with some of the brightest minds in technology. Our team doesn't shy away from tackling big... that take risks and challenge cybersecurity's status quo. It's simple: we can't accomplish our mission without diverse teams...
quo. It's simple: we can't accomplish our mission without diverse teams innovating, together. We are committed...
about cybersecurity. Our engineers don't shy away from building products to solve problems no one has pursued before. We define the... problem solvers that take risks and challenge cybersecurity's status quo. It's simple: we can't accomplish our mission...
's simple: we can't accomplish our mission without diverse teams innovating, together. We are committed to providing...